Evonik Shores Up M&A Firepower with €1.25B Bond Mandate While Reshaping Dividend Policy for Growth
03.06.2026 - 16:33:24 | boerse-global.de
Evonik’s annual shareholder meeting delivered a clear strategic blueprint on Tuesday, as the specialty chemicals group secured approval to issue up to €1.25 billion in convertible and warrant-linked bonds, providing the financial ammunition for acquisitions amid a wave of industry consolidation. The mandate, coupled with a revamped dividend framework and leadership continuity, signals that management is positioning the company for a more aggressive expansion drive.
The bond programme, which includes the creation of conditional capital of roughly 37 million new shares, offers Evonik the flexibility to pursue bolt-on deals without straining its balance sheet. The move comes as investment bank Carlyle won EU approval to acquire BASF’s paints division in a €7.7 billion transaction — a reminder that portfolio reshuffling is gathering pace across the European chemicals landscape.
Dividend Policy Gets a Structural Overhaul
Shareholders approved a €1.00 per share dividend for the past year, representing a total payout of approximately €466 million. More significantly, from 2026 the company will anchor its distribution to adjusted group net income, targeting a payout ratio of between 40% and 60%. The shift is designed to preserve investment capacity while imposing greater financial discipline — a balancing act that analysts will watch closely as the cost-cutting programme, dubbed "Evonik Tailor Made", approaches its final phase.
That efficiency drive already calls for the elimination of around 1,000 jobs globally this year, underscoring the pressure on margins in a sector facing subdued demand in several end-markets.
Should investors sell immediately? Or is it worth buying Evonik?
Leadership Locked In for the Medium Term
The supervisory board extended CEO Christian Kullmann’s contract through 2030 ahead of schedule, a move the market interpreted as a vote of confidence in the restructuring strategy. Newly appointed CFO Michael Rauch addressed investors for the first time, stepping into the role at a pivotal moment when cost reduction targets and M&A optionality are top of mind.
Political Tailwinds from Berlin and Brussels
Beyond corporate governance, two policy developments provided contextual support. Germany’s cabinet took up a circular economy action plan backed by €260 million from the Climate and Transformation Fund through 2029, targeting critical raw material recovery and recycling of batteries, wind turbines and solar modules — areas where Evonik’s specialty chemicals play an enabling role. Meanwhile, the European Commission unveiled the "InvestAI" initiative, aiming to mobilise up to €200 billion for artificial intelligence, cloud and semiconductor infrastructure. Evonik’s presence in semiconductor-grade chemicals positions it to benefit from sustained demand for advanced precursor materials.
Analyst Views Diverge on Valuation
The stock traded at €16.85 on the day, marginally below its 50-day moving average of €17.04, having rallied roughly 26.5% since the start of the year. Despite the gains, it remains about 12% shy of its 52-week high of €19.36.
Evonik at a turning point? This analysis reveals what investors need to know now.
Morgan Stanley recently lifted its price target to €19.00, while Deutsche Bank held firm at €16.00 with a "hold" rating, citing a lack of near-term catalysts to break through technical resistance at €17.30. Management reiterated its full-year guidance for adjusted EBITDA of between €1.7 billion and €2.0 billion, supported by stable demand in animal nutrition and high-performance polymers.
Whether the newly authorised bond programme translates into a concrete acquisition in the second half will likely determine the next leg of the share price trajectory. Until then, Evonik’s story remains one of cautious preparation for a more active dealmaking phase.
Ad
Evonik Stock: New Analysis - 3 June
Fresh Evonik information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
